A therapy for breast carcinoma

March 4, 2009

1: Neuro Endocrinol Lett. 2008 Dec 29;29(6). [Epub ahead of print]

Complete objective response to biological therapy of plurifocal breast

carcinoma.Di Bella GD.

Di Bella Foundation, Bologna, Italy. posta@....

In this case presentation, a woman with breast carcinoma who chose to try Prof.

L. DiBella's biological therapy (MDB), was found, after seven months, to have a

50% reduction in objective measures of her carcinoma and was totally cured after

14 months. The patient's recovery extended to bilateral axillary adenopathies,

and took place without the toxicity normally associated with cancer treatment.

MDB entails the use of anti-proliferative molecules such as somatostatine,

prolactin, and estrogen inhibitors, along with differentiating and apoptotic

molecules such as melatonin, retinoids, vitamins C, D3, and E, calcium, and

amino-sugars, combined with minimal doses of chemotherapy. The hemato-chemical

exams showed no damage, with a progressive reduction of prolactin, estradiol,

IGF1, and maintenance of low levels of GH. The achievement of objective results,

without toxicity, in this case, proves the effectiveness of this therapy and

confirms the positive results already published on the use of MDB for Low-Grade

NHL, and pulmonary carcinomas in the 3rd and 4th stages. MDB, without the need

for either hospitalization or day hospitalization, without toxicity, and without

even minimally reducing the patient's daily work routine, allowed the patient to

avoid surgical trauma and the significant collateral effects of chemo- and

radiotherapy. Timely use of MDB as the first line therapy, in a patient which

had not been debilitated by the mutagenic, toxic, and immuno-depressive effects

of chemo- and radiotherapy, contributed greatly to the final outcome. We feel it

is useful to highlight this case in an effort to stimulate interest and further

study into the oncological potential of MDB biological and receptor therapy.

PMID: 19112416 [PubMed - as supplied by publisher]

Recommended Posts